|View printer-friendly version|
|January 07, 2011 4:48 p.m.|
|Teva to Present at the 29th Annual J.P. Morgan Healthcare Conference|
|Jerusalem, Israel, January 7, 2011 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 29th Annual J.P. Morgan Healthcare Conference with Eyal Desheh, CFO, Teva Pharmaceutical Industries Ltd. and William Marth, President & CEO, Teva Pharmaceuticals - Americas, presenting on Tuesday, January 11, 2011 in San Francisco.|
What: Teva Presentation at the 29th Annual J.P. Morgan Healthcare Conference
Who: Eyal Desheh, CFO, Teva Pharmaceutical Industries and
William Marth, President & CEO, Teva Pharmaceuticals Americas
When: Tuesday, January 11th, 2011, at 1:30 PM Pacific Standard Time
Where: www.tevapharm.com/financial/ or
How: Live over the Internet log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will also be available on Teva's website.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs more than 40,000 people around the world and reached $13.9 billion in net sales in 2009.